Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Nutex Health (NUTX) Convertible Debt (2016 - 2022)

Nutex Health's Convertible Debt history spans 8 years, with the latest figure at $5400.0 for Q4 2022.

  • For Q4 2022, Convertible Debt fell 99.91% year-over-year to $5400.0; the TTM value through Dec 2022 reached $5400.0, down 99.91%, while the annual FY2022 figure was $5400.0, 99.91% down from the prior year.
  • Convertible Debt for Q4 2022 was $5400.0 at Nutex Health, down from $6.0 million in the prior quarter.
  • Across five years, Convertible Debt topped out at $6.0 million in Q4 2021 and bottomed at $1518.0 in Q1 2020.
  • The 5-year median for Convertible Debt is $394959.0 (2018), against an average of $992913.2.
  • The largest annual shift saw Convertible Debt skyrocketed 13769.44% in 2018 before it crashed 99.91% in 2022.
  • A 5-year view of Convertible Debt shows it stood at $299996.0 in 2018, then tumbled by 99.28% to $2163.0 in 2019, then dropped by 29.82% to $1518.0 in 2020, then surged by 395156.92% to $6.0 million in 2021, then plummeted by 99.91% to $5400.0 in 2022.
  • Per Business Quant, the three most recent readings for NUTX's Convertible Debt are $5400.0 (Q4 2022), $6.0 million (Q4 2021), and $1518.0 (Q1 2020).